A. Kaneko et al., 1,25-dihydroxyvitamin D-3 suppresses the expression of the VCAM-1 receptor, VLA-4 in human leukemic HL-60 cells, BIOC BIOP R, 255(2), 1999, pp. 371-376
Citations number
22
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Very late antigen-4 (VLA-4) is the complex with alpha 4 and beta 1 integrin
s, which is the receptors to fibronectin and VCAM-1. We evaluate the effect
of 1,25(OH)(2)D-3 on the expression of VLA-4 in human leukemic HL-60, U937
cells and human melanoma A375 cells. Flow cytometric analysis demonstrate
that the expression of alpha 4 integrin is negatively regulated in the cell
lines we studied. The expression of beta 1 integrin is also decreased in H
L-60 and U937 cells. The mRNA expression of alpha 4 integrin is significant
ly decreased by the treatment with 1,25(OH)(2)D-3, whereas 1,25(OH)(2)D-3 d
oes not alter the expression of beta 1 mRNA. The adhesion assay demonstrate
that the number of adherent cells treated with 1,25(OH)(2)D-3 is significa
ntly lower than that untreated on VCAM-1-coated wells. Because VCAM-1 is hi
ghly expressed in the endothelial cells, it is possible that 1,25(OH)(2)D-3
prevents the attachment of the cells from the endothelial cells in vivo. (
C) 1999 Academic Press.